Optimizing Targeted Therapy in IgVH-Unmutated CLL
EP. 1: Approaching a Case of IgVH-Unmutated CLL
Watch
EP. 2: Stratifying Patients With CLL by Stage and Risk Status
EP. 3: Optimizing Treatment Strategies for Patients With CLL
EP. 4: Ibrutinib's Role in Treating IgVH-Unmutated CLL
EP. 5: Second-Line Options in CLL: Progressing on Ibrutinib
EP. 6: Shifting the Treatment Paradigm of CLL